Alzheimer's - McKnight's Long Term Care News


Clinical Briefs for Wednesday, Nov. 6

Single odds-defying case may lead to new Alzheimer’s treatments … Fully digital Alzheimer’s study to track risk factors in 400,000 volunteers … Blood samples may identify those at risk for frailty … FDA approves Talicia® for treatment of H. pylori in adults

Clinical Briefs for Tuesday, October 29

New antiviral drug effectively treats influenza infection … Biogen’s drug news could ‘open the floodgates’ for Alzheimer’s drugs: STAT … Oscillating vest keeps COPD sufferers out of hospital … Thiazolidinedione use in diabetes linked to lower Parkinson’s risk

Clinical Briefs for Friday, October 25

Vitamin D deficiency linked to poor muscle function in seniors … Immune response to influenza is culprit in poor flu outcomes … ‘Whole concept of senior living will change’ if Alzheimer’s drug is approved … Antidepressants show little clinical benefit for major depressive disorders

Clinical Briefs for Wednesday, October 23

Surprise move: Biogen presses ahead on failed Alzheimer’s drug … Robot ‘colleague’ in pilot test for dementia patients at two nursing homes … Breaking thought patterns raises chance of depression recovery … FDA, FTC warn company that claims to treat Parkinson’s, Alzheimer’s with cannabinoids

Clinical Briefs for Wednesday, October 2

Brain protein could put the brakes on Alzheimer’s … FDA approves canagliflozin (Invokana) to treat diabetic kidney disease, heart failure … More than 80% of seniors have at least one concern about telehealth … Two of this season’s four flu vaccines may be off the mark

Clinical Briefs for Tuesday, September 3

Similar odds of dementia-type brain lesions found in heart failure, stroke patients … It’s never too late to start statins for clogged leg arteries … New brain cells play an underappreciated role in Alzheimer’s disease … Risk of breast cancer persists after hormone therapy treatment

Next post in Clinical Daily News